Science Publishing Mega-Merger

Macmillan Science and Education, the publisher of Nature and Scientific American, will join forces with Springer Science+Business Media.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NEW ZEALAND TRANSPORT AGENCYThe London-based publisher of venerated scientific journal Nature has plans to merge with one of the largest science publishers in the world, according to the two firms’ parent companies. Macmillan Science and Education, which publishes Scientific American as well as Nature, announced on Thursday (January 15) that it will merge with Berlin-based Springer Science+Business Media, the publisher of the Journal of Molecular Medicine, Clinical Pharmacokinetics, and Acta Neuropathologica, among many other titles. The merger, which still has to clear European competition regulators, was struck between Holtzbrinck Publishing Group, owner of Macmillan, and private equity firm BC Partners, which bought out Springer in 2013.

“The deal makes a lot of sense for both sides,” Claudio Aspesi, a media analyst with Sanford C. Bernstein & Co. in London, told Nature. “From BC Partners’ perspective, there were a lot of questions about what they could do with Springer when they bought it, since much cost-cutting had already been done. Now we know how you can add value to that deal — add the most prestigious journals in the world. For Holtzbrinck, the idea is presumably that they get additional scale for Macmillan, which will give additional funds for any new plans.”

Springer is a giant in the academic publishing world, hosting almost 3,000 titles. Macmillan only publishes 160 journals, but among them are Nature and the associated research journals. “Combined, these ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio